Thawing System Market Size

Thawing System Market Analysis

The thawing system market studied is expected to register a CAGR of nearly 12.8% over the forecast period.

• The COVID-19 pandemic had a significant impact on the thawing system market, primarily due to the increased utilization of thawing systems for transporting vaccines and swabs to keep them viable for testing. For example, a December 2022 article published in MedRxiv notes that ultra-low temperature preservation has been the gold standard for the long-term storage of several types of clinical specimens, including the SARS-CoV-2 virus. Frozen specimens are easily transportable and can be analyzed at a later date, and de-identified frozen residual samples can be used in a variety of preclinical and clinical research. 
• Additionally, freezing and thawing do not significantly affect the testing results when making dilutions or testing clinical samples on rapid test kits. Therefore, COVID-19 had a significant impact on the thawing system market. However, with the resumption of laboratory services and decreasing cases of COVID-19, the studied market is expected to witness stable growth over the forecast period.
• The major factors driving the growth of the market include increasing usage of thawing devices in various applications and increasing demand for thawed cells for the treatment of different diseases. Furthermore, the growing investments in research and development programs by biotechnology and pharmaceutical companies are boosting market growth. For instance, an April 2022 article published in PubMed suggests that targeted research into optimizing cryopreservation and freeze-thawing routines, as well as the design of adjunct manufacturing processes, may provide critical advantages in improving the safety and efficacy of cellular therapeutics in clinical use. This research also enables effective market deployment strategies to become economically viable and sustainable medicines. 
• Furthermore, many comparative studies with thawing systems and technological advancements are likely to increase the utilization of the thawing system. For example, in November 2022, BioLife Solutions, Inc., a developer, and supplier of class-defining bioproduction products and services for cell and gene therapy (CGT) and the broader biopharma markets, provided an update on the expansion of its intellectual property estate. The company received notice of the granting of seven patents by the USPTO and other patent authorities outside the United States and filed 43 new applications for novel inventions related to its cell processing, media, storage containers, freezers, and thaw systems platforms, several of which are specific to BioLife's proprietary Stirling engine technologies. 
• In December 2021, Sartorius and HOF Sonderanlagenbau entered into a partnership to integrate two HOF horizontal plate freeze-thaw units into Sartorius' portfolio, offering customers a full suite of compatible freeze-thaw equipment and consumables. This partnership enabled faster and easier implementation of robust frozen drug substance management platforms through improved validation and purchase support from a single supplier.
• Thus, with the increase in demand for thawing systems and rapid technological advancements, the studied market is expected to witness significant growth over the forecast period. However, the high cost of automatic devices remains a major drawback to market growth.